Levy Raphi reported option exercise involving 2,871 shares of Alpha Tau Medical Ltd. at $2.98 for $8.56k on Aug 21, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Chief Financial Officer
Chief Financial Officer
Filed Aug 25, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$8,555.58Shares × reported price
Shares traded
2,871Ordinary Shares
Price per share
$2.98Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
93,051Direct
Trade date
Aug 21, 2026Option exercise
Filed
Aug 25, 2026, 10:34 AM ET4-day reporting delay
Accession
0001213900-26-093335Code M · Transaction 97637
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 21, 2026Sell2,871$15.00−$43,073.04Trade 97638
2 transaction rows in this filing. Joint filers share the same rows.

DRTS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
DRTS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Sep 1, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

No footnotes recorded. Check the original SEC filing for the complete report.